tiprankstipranks
3SBio (DE:83B)
FRANKFURT:83B
Germany Market
83B
3SBio
RESEARCH TOOLSreports

3SBio (83B) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

83B Analyst Ratings

Strong Buy
7Ratings
Strong Buy
6 Buy
1 Hold
0 Sell
Based on 7 analysts giving stock ratings to
3SBio
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

83B Stock 12 Month Forecast

Average Price Target

€3.87
▲(43.68% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for 3SBio in the last 3 months. The average price target is €3.87 with a high forecast of €4.22 and a low forecast of €3.24. The average price target represents a 43.68% change from the last price of €2.69.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"€0","5":"€5","1.25":"€1.25","2.5":"€2.5","3.75":"€3.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":4.2208132,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€4.22</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.8650117142857146,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€3.87</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.24330372,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€3.24</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1.25,2.5,3.75,5],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.961,2.134831784615385,2.3086635692307693,2.482495353846154,2.6563271384615383,2.8301589230769233,3.003990707692308,3.1778224923076923,3.3516542769230773,3.5254860615384613,3.6993178461538463,3.8731496307692312,4.046981415384615,{"y":4.2208132,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.961,2.1074624395604395,2.2539248791208792,2.400387318681319,2.546849758241758,2.693312197802198,2.8397746373626376,2.986237076923077,3.132699516483517,3.279161956043956,3.425624395604396,3.5720868351648356,3.718549274725275,{"y":3.8650117142857146,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.961,2.0596387476923077,2.1582774953846156,2.2569162430769234,2.355554990769231,2.4541937384615387,2.5528324861538465,2.651471233846154,2.7501099815384618,2.8487487292307696,2.947387476923077,3.0460262246153844,3.1446649723076927,{"y":3.24330372,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.083,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.539,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.3,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.26,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.2,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.36,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.44,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.639,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.44,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.18,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.7,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.46,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.961,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€4.22Average Price Target€3.87Lowest Price Target€3.24
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS Analyst forecast on DE:83B
Unknown Analyst
UBS
Not Ranked
UBS
€4.15→€4.19
Buy
55.68%
Upside
Reiterated
05/27/26
UBS Remains a Buy on 3SBio (TRSBF)
CMB International Securities Analyst forecast on DE:83B
Jill Wu
CMB International Securities
CMB International Securities
€3.84
Buy
42.86%
Upside
Reiterated
05/26/26
Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (NASDAQ: DYN), Kura Oncology (NASDAQ: KURA) and 3SBio (Other OTC: TRSBF)
Goldman Sachs Analyst forecast on DE:83B
Ziyi Chen
Goldman Sachs
Goldman Sachs
€3.66→€3.24
Hold
20.57%
Upside
Reiterated
04/02/26
Goldman Sachs Remains a Hold on 3SBio (TRSBF)
Bank of China Analyst forecast on DE:83B
Unknown Analyst
Bank of China
Not Ranked
Bank of China
€4.22
Buy
56.91%
Upside
Reiterated
04/01/26
Bank of China Remains a Buy on 3SBio (TRSBF)
CICC Analyst forecast on DE:83B
Unknown Analyst
CICC
Not Ranked
CICC
€4.02
Buy
49.53%
Upside
Reiterated
04/01/26
CICC Reaffirms Their Buy Rating on 3SBio (TRSBF)
BOCOM International Holdings Company Analyst forecast on DE:83B
Unknown Analyst
BOCOM International Holdings Company
Not Ranked
BOCOM International Holdings Company
€3.57
Buy
32.74%
Upside
Reiterated
04/01/26
BOCOM International Holdings Company Remains a Buy on 3SBio (TRSBF)
Citi Analyst forecast on DE:83B
Unknown Analyst
Citi
Not Ranked
Citi
€3.97
Buy
47.48%
Upside
Reiterated
03/31/26
Citi Reaffirms Their Buy Rating on 3SBio (TRSBF)
Morgan Stanley Analyst forecast on DE:83B
Alexis Yan
Morgan Stanley
Morgan Stanley
€4.19
Buy
55.68%
Upside
Reiterated
01/13/26
Morgan Stanley Reaffirms Their Buy Rating on 3SBio (TRSBF)
Guoyuan Securities (HK) Analyst forecast on DE:83B
Unknown Analyst
Guoyuan Securities (HK)
Not Ranked
Guoyuan Securities (HK)
€3.61
Buy
34.21%
Upside
Reiterated
01/04/26
3SBio (TRSBF) Gets a Buy from Guoyuan Securities (HK)
Guotai Haitong Analyst forecast on DE:83B
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
€5.27
Buy
95.99%
Upside
Reiterated
11/29/25
Guotai Haitong Remains a Buy on 3SBio (TRSBF)
Citic Securities Analyst forecast on DE:83B
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
€4.74
Buy
76.16%
Upside
Reiterated
11/26/25
Citic Securities Remains a Buy on 3SBio (TRSBF)
Huatai Securities Analyst forecast on DE:83B
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
€5.15
Buy
91.61%
Upside
Reiterated
11/05/25
Huatai Securities Remains a Buy on 3SBio (TRSBF)
KeyBanc Analyst forecast on DE:83B
Unknown Analyst
KeyBanc
Not Ranked
KeyBanc
€4.66
Buy
73.29%
Upside
Reiterated
09/21/25
CLSA Analyst forecast on DE:83B
David Dong
CLSA
CLSA
€2.16→€4.09
Buy
51.99%
Upside
Reiterated
09/02/25
CLSA Sticks to Its Buy Rating for 3SBio (TRSBF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS Analyst forecast on DE:83B
Unknown Analyst
UBS
Not Ranked
UBS
€4.15→€4.19
Buy
55.68%
Upside
Reiterated
05/27/26
UBS Remains a Buy on 3SBio (TRSBF)
CMB International Securities Analyst forecast on DE:83B
Jill Wu
CMB International Securities
CMB International Securities
€3.84
Buy
42.86%
Upside
Reiterated
05/26/26
Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (NASDAQ: DYN), Kura Oncology (NASDAQ: KURA) and 3SBio (Other OTC: TRSBF)
Goldman Sachs Analyst forecast on DE:83B
Ziyi Chen
Goldman Sachs
Goldman Sachs
€3.66→€3.24
Hold
20.57%
Upside
Reiterated
04/02/26
Goldman Sachs Remains a Hold on 3SBio (TRSBF)
Bank of China Analyst forecast on DE:83B
Unknown Analyst
Bank of China
Not Ranked
Bank of China
€4.22
Buy
56.91%
Upside
Reiterated
04/01/26
Bank of China Remains a Buy on 3SBio (TRSBF)
CICC Analyst forecast on DE:83B
Unknown Analyst
CICC
Not Ranked
CICC
€4.02
Buy
49.53%
Upside
Reiterated
04/01/26
CICC Reaffirms Their Buy Rating on 3SBio (TRSBF)
BOCOM International Holdings Company Analyst forecast on DE:83B
Unknown Analyst
BOCOM International Holdings Company
Not Ranked
BOCOM International Holdings Company
€3.57
Buy
32.74%
Upside
Reiterated
04/01/26
BOCOM International Holdings Company Remains a Buy on 3SBio (TRSBF)
Citi Analyst forecast on DE:83B
Unknown Analyst
Citi
Not Ranked
Citi
€3.97
Buy
47.48%
Upside
Reiterated
03/31/26
Citi Reaffirms Their Buy Rating on 3SBio (TRSBF)
Morgan Stanley Analyst forecast on DE:83B
Alexis Yan
Morgan Stanley
Morgan Stanley
€4.19
Buy
55.68%
Upside
Reiterated
01/13/26
Morgan Stanley Reaffirms Their Buy Rating on 3SBio (TRSBF)
Guoyuan Securities (HK) Analyst forecast on DE:83B
Unknown Analyst
Guoyuan Securities (HK)
Not Ranked
Guoyuan Securities (HK)
€3.61
Buy
34.21%
Upside
Reiterated
01/04/26
3SBio (TRSBF) Gets a Buy from Guoyuan Securities (HK)
Guotai Haitong Analyst forecast on DE:83B
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
€5.27
Buy
95.99%
Upside
Reiterated
11/29/25
Guotai Haitong Remains a Buy on 3SBio (TRSBF)
Citic Securities Analyst forecast on DE:83B
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
€4.74
Buy
76.16%
Upside
Reiterated
11/26/25
Citic Securities Remains a Buy on 3SBio (TRSBF)
Huatai Securities Analyst forecast on DE:83B
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
€5.15
Buy
91.61%
Upside
Reiterated
11/05/25
Huatai Securities Remains a Buy on 3SBio (TRSBF)
KeyBanc Analyst forecast on DE:83B
Unknown Analyst
KeyBanc
Not Ranked
KeyBanc
€4.66
Buy
73.29%
Upside
Reiterated
09/21/25
CLSA Analyst forecast on DE:83B
David Dong
CLSA
CLSA
€2.16→€4.09
Buy
51.99%
Upside
Reiterated
09/02/25
CLSA Sticks to Its Buy Rating for 3SBio (TRSBF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering 3SBio

3 Months
Jill WuCMB International Securities
Success Rate
3/10 ratings generated profit
30%
Average Return
+20.88%
Copying Jill Wu's trades and holding each position for 3 Months would result in 30.00% of your transactions generating a profit, with an average return of +20.88% per trade.
1 Year
Jill WuCMB International Securities
Success Rate
4/10 ratings generated profit
40%
Average Return
+113.69%
Copying Jill Wu's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of +113.69% per trade.
2 Years
Jill WuCMB International Securities
Success Rate
4/10 ratings generated profit
40%
Average Return
+52.76%
Copying Jill Wu's trades and holding each position for 2 Years would result in 40.00% of your transactions generating a profit, with an average return of +52.76% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

83B Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
2
4
6
4
Buy
3
3
2
2
2
Hold
1
1
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
6
7
9
7
In the current month, 83B has received 6 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 83B average Analyst price target in the past 3 months is 3.87.
Each month's total comprises the sum of three months' worth of ratings.

83B Financial Forecast

83B Earnings Forecast

Next quarter’s earnings estimate for 83B is €0.08 with a range of €0.08 to €0.08. The previous quarter’s EPS was €0.37. 83B beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 83B has Performed in-line its overall industry.
Next quarter’s earnings estimate for 83B is €0.08 with a range of €0.08 to €0.08. The previous quarter’s EPS was €0.37. 83B beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 83B has Performed in-line its overall industry.

83B Sales Forecast

Next quarter’s sales forecast for 83B is €595.15M with a range of €595.15M to €595.15M. The previous quarter’s sales results were €1.60B. 83B beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 83B has Performed in-line its overall industry.
Next quarter’s sales forecast for 83B is €595.15M with a range of €595.15M to €595.15M. The previous quarter’s sales results were €1.60B. 83B beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 83B has Performed in-line its overall industry.

83B Stock Forecast FAQ

What is DE:83B’s average 12-month price target, according to analysts?
Based on analyst ratings, 3SBio’s 12-month average price target is 3.87.
    What is DE:83B’s upside potential, based on the analysts’ average price target?
    3SBio has 43.68% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is 3SBio a Buy, Sell or Hold?
          3SBio has a consensus rating of Strong Buy, which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.
            What is 3SBio’s share price target?
            The average share price target for 3SBio is 3.87. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €4.22 ,and the lowest forecast is €3.24. The average share price target represents 43.68% Increase from the current price of €2.69.
              What do analysts say about 3SBio?
              3SBio’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of 3SBio?
                To buy shares of DE:83B, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.